JP2010521418A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521418A5 JP2010521418A5 JP2009539559A JP2009539559A JP2010521418A5 JP 2010521418 A5 JP2010521418 A5 JP 2010521418A5 JP 2009539559 A JP2009539559 A JP 2009539559A JP 2009539559 A JP2009539559 A JP 2009539559A JP 2010521418 A5 JP2010521418 A5 JP 2010521418A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- amino acid
- acid sequence
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89478607P | 2007-03-14 | 2007-03-14 | |
| US60/894,786 | 2007-03-14 | ||
| PCT/JP2008/055344 WO2008114876A1 (en) | 2007-03-14 | 2008-03-14 | A method of treating malignant mesothelioma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010521418A JP2010521418A (ja) | 2010-06-24 |
| JP2010521418A5 true JP2010521418A5 (https=) | 2011-03-03 |
| JP4865868B2 JP4865868B2 (ja) | 2012-02-01 |
Family
ID=39765975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539559A Active JP4865868B2 (ja) | 2007-03-14 | 2008-03-14 | 悪性中皮種の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20100135993A1 (https=) |
| EP (1) | EP2131863A4 (https=) |
| JP (1) | JP4865868B2 (https=) |
| CA (1) | CA2680368A1 (https=) |
| WO (1) | WO2008114876A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2403877B1 (en) * | 2009-03-06 | 2015-05-06 | Klaus Tschira Stiftung GgmbH | Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient |
| US20120045435A1 (en) * | 2010-08-18 | 2012-02-23 | Theresa Deisher | Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| JP2015030666A (ja) | 2013-07-31 | 2015-02-16 | 学校法人順天堂 | 抗ヒトｃｄ２６モノクローナル抗体又はその抗原結合性断片 |
| JP6931228B2 (ja) * | 2015-09-11 | 2021-09-01 | ワイズ・エー・シー株式会社 | 抗ｃｄ２６抗体と他の抗癌剤とを組み合わせた癌治療用組成物 |
| US10282369B2 (en) * | 2017-03-08 | 2019-05-07 | Centri Technology, Inc. | Fast indexing and searching of encoded documents |
| JP7064203B2 (ja) * | 2018-03-16 | 2022-05-10 | 学校法人順天堂 | 抗ヒトｃｄ２６モノクローナル抗体 |
| WO2022066847A1 (en) * | 2020-09-24 | 2022-03-31 | Alnylam Pharmaceuticals, Inc. | Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereof |
| KR20240007229A (ko) * | 2021-05-13 | 2024-01-16 | 아디에네 에스.에이. | 이식편 대 숙주 질환을 치료하는 방법 |
| US20250340665A1 (en) | 2021-05-13 | 2025-11-06 | Adienne S.A. | Methods of treating dermatomyositis |
| WO2022255248A1 (ja) * | 2021-05-31 | 2022-12-08 | ワイズ・エー・シー株式会社 | 抗ｃｄ２６抗体と免疫チェックポイント阻害剤との併用療法 |
| CN116023491A (zh) * | 2021-10-25 | 2023-04-28 | 江苏众红生物工程创药研究院有限公司 | 抗cd26抗体及其应用 |
| CN116549629A (zh) * | 2022-01-30 | 2023-08-08 | 江苏众红生物工程创药研究院有限公司 | Cd45作为生物标志物在筛查cd26抗体或其衍生物治疗肿瘤有效性和精准性中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100863624B1 (ko) * | 2001-05-11 | 2008-10-15 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | Ｃｄ26을 발현하는 세포와 연관된 질환의 치료제로사용되는 항-ｃｄ26 단클론항체 |
| US20030138429A1 (en) * | 2001-05-22 | 2003-07-24 | Pizzo Salvatore V. | Compositions and methods for inhibiting metastasis |
| EP1907425B1 (en) * | 2005-07-22 | 2014-01-08 | Y's Therapeutics Co., Ltd. | Anti-cd26 antibodies and methods of use thereof |
-
2008
- 2008-03-14 EP EP08722664A patent/EP2131863A4/en not_active Withdrawn
- 2008-03-14 US US12/450,223 patent/US20100135993A1/en not_active Abandoned
- 2008-03-14 WO PCT/JP2008/055344 patent/WO2008114876A1/en not_active Ceased
- 2008-03-14 CA CA002680368A patent/CA2680368A1/en not_active Abandoned
- 2008-03-14 JP JP2009539559A patent/JP4865868B2/ja active Active
-
2012
- 2012-02-07 US US13/385,206 patent/US8771688B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521418A5 (https=) | ||
| CN104593332B (zh) | 一种检测小麦矮腥黑粉菌的试剂盒及方法 | |
| NZ602056A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP1996940A4 (en) | DETECTION OF CANCER DUE TO INCREASED BCL-2 CONCENTRATIONS | |
| Zhao et al. | Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination | |
| Maizel et al. | Urinary TIMP2 and IGFBP7 identifies high risk patients of short‐term progression from mild and moderate to severe acute kidney injury during septic shock: a prospective cohort study | |
| CN108449999B (zh) | 使用色酰胺-tRNA合成酶诊断感染病或其并发症的组合物以及检测诊断标记物的方法 | |
| Wang et al. | Establishment of a quantitative polymerase chain reaction assay for monitoring chimeric antigen receptor T cells in peripheral blood | |
| Rha et al. | SARS-CoV-2 spike-specific nasal-resident CD49a+ CD8+ memory T cells exert immediate effector functions with enhanced IFN-γ production | |
| WO2006116442A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| Wei et al. | Ultrasensitive “hunter of target”: rabbit monoclonal antibody-based competitive lateral flow immunoassay for saxitoxin | |
| WO2010035259A3 (en) | Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll | |
| JP6122437B2 (ja) | 生存可能な内生菌検出 | |
| JP2008500833A5 (https=) | ||
| IL190401A0 (en) | Antibodies against april as biomarkers for early prognosis of lymphoma patients | |
| CN113278691B (zh) | 一种长非编码rna及其在诊断/治疗类风湿关节炎中的应用 | |
| CN110669818A (zh) | 多发性骨髓瘤肠道微生物标志物及应用和检测制剂 | |
| GB2568617A (en) | Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV), and use thereof in a diagnostic method | |
| CN102268409B (zh) | 一种抗人蛋白rn181的单克隆抗体及杂交瘤细胞株3952与试剂盒 | |
| IN2012DN02304A (https=) | ||
| Zhao et al. | Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features | |
| WO2024103504A1 (zh) | 一种检测炎症相关疾病的标志物和方法 | |
| JP2007145775A (ja) | ノロウイルスｇｉの高感度検出方法 | |
| CN110499365A (zh) | Agap9在制备诊断骨关节炎的产品中的应用 | |
| US20250346658A1 (en) | Methods for detecting or treating atherosclerosis |